Home » Topics » BioWorld Science

BioWorld Science
RSS

New CDK8/19 inhibitors described by Biocad CJSC

Feb. 21, 2020

AT-845 shows safety and robust efficacy in preclinical models

Feb. 21, 2020

BT-200 blocks VWF and platelet function in whole blood of patients with acute stroke

Feb. 21, 2020

Results from ongoing phase I study of ciforadenant with or without atezolizumab in mCRPC

Feb. 21, 2020

VBL initiates phase II study of VB-111 and nivolumab in metastatic colorectal cancer

Feb. 21, 2020

Novartis initiates first-in-human trial of WVT-078 in multiple myeloma

Feb. 21, 2020

Enrollment ongoing in phase I/II study of MB-102

Feb. 21, 2020

Mesoblast reports clinically meaningful outcomes for remestemcel-L in chronic GVHD

Feb. 21, 2020

Passengers, noncoding genome affect how cancers play out

Feb. 21, 2020

FDA approves IND application for phase IIb study of CMN-001 in advanced RCC

Feb. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...